CompaniesHaemostatix

Haemostatix

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

189

By Phase

PHASE2: 1PHASE1: 1

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
Today
NCT02204930
Hover over trial bars to see details

Recent Trials

NCT03131336Lead Sponsor
PeproStat as a Topical Agent Used to Stop Bleeding in Patients Undergoing Surgery
PHASE2Completed
169 participants
Started: Mar 31, 2017 · Completed: Oct 11, 2017
NCT02204930Lead Sponsor
PeproStat Haemostat Study in Subjects Undergoing Liver Surgery
PHASE1Completed
20 participants
Started: Jul 31, 2014 · Completed: Sep 30, 2015
Related Companies
Ergomed
acquired